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Abstract
Background: During cardiac arrest, end-tidal carbon dioxide (ETCO2) monitoring is recommended as a chest
compression performance indicator. However, its frequency of use during out-of-hospital cardiac arrest (OHCA) and
its benefits have never been evaluated in real clinical situations.
Objective: We investigated OHCA patients in Taiwan to evaluate the frequency of ETCO2 monitoring and its effects
on sustained return of spontaneous circulation (ROSC).
Methods: We sampled the Taiwan National Health Insurance claims database, which contains 1 million beneficiaries.
All adult beneficiaries older than 18 years who presented with OHCA and received chest compression between 1
January 2005 and 31 December 2012 were enrolled. We further identified patients with ETCO2 monitoring and
matched each 1 with 20 patients who did not receive ETCO2 monitoring based on their propensity scores. A simple
conditional logistic regression model was applied to compare the odds ratio (OR) for sustained ROSC in the matched
cohorts.
Results: A total of 5041 OHCA patients were enrolled. The frequency of ETCO2 monitoring has increased since 2010
but still is low. After matching, 53 patients with ETCO2 monitoring and 1060 without ETCO2 monitoring were selected.
The OR of sustained ROSC in the ETCO2 group was significantly increased (2.38, 95 % CI 1.28–4.42).
Conclusion: Patients who received ETCO2 monitoring during OHCA had a higher possibility of sustained ROSC, but the
overall use of ETCO2 monitoring is still low despite strong recommendations for its use.
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Introduction
Out-of-hospital cardiac arrest (OHCA) is a major cause
of morbidity and mortality around the world. In the
United States, the estimated annual incidence of OHCA
ranges from 300,000 to 350,000 each year [1, 2]. Wider
application of the improved algorithms in the Advanced
Cardiac Life Support (ACLS) recommendations, such as
early defibrillation and high-quality cardiopulmonary re-
suscitation (CPR), have led to increased survival rates
among OHCA patients [3–5]. Because CPR consistency
is an important factor, end-tidal carbon dioxide (ETCO2)
monitoring has recently been suggested as an adjunctive
tool for monitoring the effectiveness of chest compres-
sions during resuscitations [3, 6].
The height of the ETCO2 level during CPR is well cor-
related with cardiac output during chest compression
[7–9], and feedback about an inadequate level can help
the team to evaluate possible causes such as misplaced
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or displaced tracheal tube, fatigue of the team member,
suboptimal chest compressions, cardiac tamponade, or
pneumothorax. In this way the resuscitation can be indi-
vidualized, and better CPR delivery may be achieved.
However, to our knowledge, despite the strong recom-
mendations from ACLS, the frequency of ETCO2 use
during OHCA and its possible influence on CPR quality
and survival, have not been evaluated in population-
based studies.
In this study, a large administrative database was used
to assess sustained ROSC in OHCA patients who were
treated with ETCO2 monitoring in Taiwan. We hypothe-
sized that use of ETCO2 monitoring may be associated
with a higher possibility of sustained ROSC because of
real-time feedback about the quality of chest compres-
sion. The results of this study may help clinicians to
place more emphasis on the use of ETCO2 monitoring
in frequently encountered situations.
Methods
Ethics statement
This study was initiated after its protocol was approved
by the Institutional Review Board of Dalin Tzu Chi Hos-
pital, Buddhist Tzu Chi Medical Foundation, Taiwan,
and was conducted in conformity with the Declaration
of Helsinki.
Database
The National Health Insurance (NHI) program was im-
plemented in Taiwan in 1995 and provides compulsory
universal health insurance. It enrolls about 99 % of the
Taiwanese population and contracts with 97 % of all the
country’s medical providers [10, 11]. The database con-
tains comprehensive information about all insured sub-
jects, including sex, date of birth, residential or work
area, dates of clinical visits, diagnoses identified by Inter-
national Classification of Diseases (Ninth Revision) Clin-
ical Modification (ICD-9-CM) diagnostic codes, details
of prescribed medications and procedures administered,
expenditure amounts, and outcome at hospital discharge
(i.e., recovered, died, or transferred out) [12]. A random
sample of 1,000,000 people who received health benefits
from the NHI program was selected based on calendar-
year 2005 reimbursement data and was considered rep-
resentative of the entire population; according to the
Taiwan National Health Research Institute, the group
did not differ statistically from the larger cohort in age,
sex, or health care costs [13, 14]. This sample was used
as our study cohort.
Study population
The population sample was followed from 1 January
2003 to 31 December 2012 (a total of 10 years). For our
study cohort, we first identified individuals who were
still alive in 2005 and were older than 18 years at the
time of OHCA. OHCA was defined by the ICD-9-CM
codes ventricular fibrillation (427.4), cardiac arrest
(427.5), and sudden death (798.0–798.9) in outpatient
clinic records. To avoid including patients who had Do
Not Attempt Resuscitation orders, no chance of survival,
and coding errors, we excluded patients on whom no
chest compression was attempted. ETCO2 monitoring
was defined by the charge record for continuous capno-
graphy during the visits. For each charge record of
ETCO2, the institutes could claim for about US$ 14
from the Bureau of National Health Insurance. After ex-
clusions, we identified 83 patients who received ETCO2
monitoring and 4958 who did not receive such monitor-
ing. In order to identify sustained ROSC, each patient
was tracked if he or she was hospitalized after OHCA
(Fig. 1).
Prespecified covariates
In order to investigate a significant influence on survival
associated with ETCO2-monitoring, we included several
covariates in the analysis; age, sex, calendar year,
urbanization level (i.e., urban, suburban, and rural),
health care institutes, and socioeconomic status (SES).
Income-related insurance payment amounts were used
as a proxy measure of individual SES at follow-up.
People were divided into 3 groups: (1) low SES: payment
lower than US$571 per month (New Taiwan Dollars
[NT$] 20,000); (2) moderate SES: payment between
US$571 and US$1141 per month (NT$ 20,000–40,000);
and (3) high SES: payment of US$1142 or more per
month (NT$40,001 or more) [12]. The health care insti-
tutes visited by patients were classified into 4 levels
(medical centers, regional hospitals, local hospitals, and
clinics) based on hospital accreditation. Two additional
covariates that may be related to sustained ROSC follow-
ing resuscitation, the CPR duration and attempted defib-
rillation, were identified based on charge records.
Finally, the prevalence of selected comorbid conditions
(i.e., diabetes, hypertension, coronary artery disease,
hyperlipidemia, malignancies, heart failure, atrial fibrilla-
tion, intracranial hemorrhage, ischemic stroke, chronic
renal insufficiency, and liver cirrhosis) and the Charlson
Comorbidity Index (CCI) score were determined using
discharge diagnoses either during outpatient clinic visits
or hospitalizations before 1 January 2005. The CCI is a
scoring system that assigns weights to important con-
comitant diseases; it has been validated for use in studies
that employ ICD-9-CM data [14, 15].
Propensity score methods
In this study, the propensity score was the conditional
probability for using ETCO2 monitoring in the presence
of possible confounders. The prespecified covariates
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were added into a multivariable logistic regression model
to predict the probability of ETCO2 use. The predicted
probability from the model was used as the propensity
score for each patient. We then matched each patient in
the ETCO2 group to 20 patients in the untreated group
with the closest propensity score using a standard
greedy-matching algorithm [16] and compared the prob-
ability of survival benefits between these groups.
Statistical analysis
The SAS statistical package, version 9.4 (SAS Institute, Inc.,
Cary, NC, USA) was used for data analysis. All covariates
were taken as categorical variables except age, calendar
year, CPR duration, and propensity score, which were
treated as continuous variables. Categorical variables were
compared using Pearson’s chi-square test, and continuous
variables were assessed using the t test to determine base-
line heterogeneity in the 2 groups. Simple conditional logis-
tic regression models were then used to calculate the ORs
of sustained ROSC and survival to hospital discharge for
patients with ETCO2 use in the matched group.
In order to further assess the robustness of our results,
we sampled another cohort by matching each patient in
the ETCO2 group to 4 patients in the untreated group
Fig. 1 Flow diagram of the population-based study
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using the same method (Fig. 1). We compared the crude
ORs and risk differences of survival benefits among 2
matched cohorts and the original group to evaluate if
the results are similar. We also evaluated the extent of
the effect of a potentially unmeasured confounder in ac-
counting for the results [17]. A two-tailed P value of
0.05 was considered significant.
Results
The distribution of demographic characteristics and se-
lected morbidities in both groups is shown in Table 1.
There were 6909 episodes of OHCA during the 8-year
period. The population incidence of OHCA in Taiwan
was 86.3 per 100,000 person-years. After exclusion, there
were 83 patients in the ETCO2 group and 4958 in the
untreated group. The overall baseline characteristics are
similar between the 2 groups, except the patients moni-
tored with ETCO2 were more likely to have liver cirrho-
sis. In addition, patients who visited medical centers also
had a higher probability of receiving ETCO2 monitoring.
The proportion of ETCO2 use gradually increased after
2010 but still was low. In 2012, only 5.8 % of OHCA
Table 1 Baseline characteristics of the ETCO2 group and the untreated group
Variables ETCO2 group Untreated group P value
(n = 83) (n = 4958)
Male, no. (%) 44 53.0 3138 63.3 0.054
Mean age in years (SD) 71.3 15.2 67.9 17.6 0.088
Attempted defibrillation, no. (%) 14 16.9 878 17.7 0.842
Mean CPR time (10 min) (SD) 2.4 1.4 2.4 1.6 0.927
Socioeconomic status, no. (%) 0.236
Low 56 67.5 3586 72.3
Moderate 26 31.3 1212 24.5
High 1 1.2 160 3.2
Urbanization level, no. (%) 0.118
Urban 26 31.3 1174 23.7
Suburban 29 35.0 2259 45.6
Rural 28 33.7 1525 30.7
Diabetes, no. (%) 25 30.1 1255 25.3 0.318
Hypertension, no. (%) 43 51.8 2434 49.1 0.624
Coronary artery disease, no. (%) 16 19.3 1075 21.7 0.598
Hyperlipidemia, no. (%) 21 25.3 893 18.0 0.087
Malignancies, no. (%) 6 7.2 231 4.7 0.273
Heart failure, no. (%) 1 1.2 255 5.1 0.105
Atrial fibrillation, no. (%) 3 3.6 107 2.2 0.368
Charlson comorbidity index score, no. (%) 0.821
0 25 30.1 1631 32.9
1 24 28.9 1307 26.4
≥ 2 34 41.0 2020 40.7
Intracerebral hemorrhage, no. (%) 1 1.2 108 2.2 0.545
Ischemic stoke, no. (%) 16 19.3 887 17.9 0.744
Chronic renal insufficiency, no. (%) 2 2.4 233 4.7 0.326
Liver cirrhosis, no. (%) 16 19.3 550 11.1 0.019
Health care institutes, no. (%) <0.001
Medical centers 36 43.4 1108 22.3
Regional hospitals 41 49.4 2497 50.4
Local hospitals 6 7.2 1333 26.9
Clinics 0 0 20 0.4
Mean propensity score (SD) 0.046 0.041 0.016 0.021 <0.001
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patients received ETCO2 monitoring (Table 2). Detailed
information about the frequency of ETCO2 use are sum-
merized in the Additional file 1. After resuscitation, 658
patients (13 %) had records of sustained ROSC, includ-
ing 25 patients in the ETCO2 group and 633 in the un-
treated group. Among them, 1 patient (4 %) in the
ETCO2 group and 96 (15.2 %) in the untreated group
had a record of survival to hospital discharge, respect-
ively. The crude odds ratio (OR) of sustained ROSC for
the ETCO2 group was 2.95 (95 % CI 1.83–4.74).
Next, 53 patients in the ETCO2 group and 1060 in the
untreated group were selected after propensity score
matching algorithm. In the subcohort, 165 patients sur-
vived, including 15 in the ETCO2 group and 150 in the
untreated group. Among them, 1 patient (6.7 %) in the
ETCO2 group and 22 (14.7 %) in the untreated group
had a record of survival to hospital discharge, respect-
ively. The basic characteristics of these 2 subgroups are
summarized in Table 3. After matching, all baseline
characteristics were similar between the 2 groups. A
simple conditional logistic regression model was used to
estimate the OR for sustained ROSC and remained sig-
nificantly higher in patients with ETCO2 use (2.38, 95 %
CI 1.28–4.42, P = 0.006). A simple conditional logistic
regression model was again used to estimate the OR of
survival to hospital discharge but failed to find treatment
benefit regarding ETCO2 use (OR 0.91, 95 % CI 0.12–
6.90 P = 0.924).
Crude ORs and risk differences among the original
group and two matched cohorts were found to be simi-
lar. The results are summarized in Table 4. Sensitivity
analyses showed that an unmeasured confounder
present in 10 % of the study population would be re-
quired to elevate the possibility of sustained ROSC by a
factor of 3.2. Among patients with ETCO2 use, the con-
founder also would have to be approximately 3.2 times
more prevalent than that among the untreated group in
order to explain a lower 95 % confidence limit HR of
1.28 (Fig. 2).
Discussion
The ACLS guideline for using ETCO2 monitoring during
CPR provides the basis on which providers can have
real-time feedback about the quality of chest compres-
sions, thus offering patients a better chance of survival
[18, 19]. To our knowledge, ours is the first study re-
garding possible survival benefits with ETCO2 monitor-
ing in real clinical situations. In this study, we evaluated
the sustained ROSC of patients in Taiwan who received
ETCO2 monitoring following OHCA. The database cor-
responded well to the characteristics of the whole popu-
lation; therefore, loss of follow-up or selection bias were
not concerns. Although the overall survival rates of
OHCA patients in Asia were found to be low [20], pa-
tients with ETCO2 monitoring during resuscitation still
had a higher possibility of sustained ROSC (OR 2.38,
95 % CI 1.28–4.42). Although there were relatively few
patients in the treatment group, based on our sample
size of matched cohort and ORs the statistical power still
achieved 1.0.
ETCO2 monitoring by itself cannot directly improve
the quality of CPR administered. However, based on the
real-time feedback about the patient’s ETCO2 level, the
code team can adjust their management to achieve bet-
ter chest compression quality, which may in turn result
in a better outcome. Moreover, ETCO2 monitoring may
also serve as a proxy for better team performance be-
cause teams or institutes that use ETCO2 monitoring
may have better insights about the importance of CPR
performance and thus may have better outcomes. In-
creased CPR quality may increase the probability of the
return of spontaneous circulation. However, in the ab-
sence of data linking ETCO2 measurements with the
quality markers of chest compressions in our study, no
causality inference can be drawn currently.
This study is also the first one based on national data
about the use of capnography during OHCA. Despite of
the strong recommendation for its use, ETCO2 monitor-
ing in OHCA patients is still low in Taiwan. Even in
2012, the overall percentage of ETCO2 monitoring was
only 5.84 %. According to the recommendations of the
ACLS guidelines and the possible survival benefits found
in this study, further emphasis should be placed on the
routine use of ETCO2 monitoring during OHCA.
Limitations
First, our findings were generated from administrative
data. The definitions of OHCA were based on ICD-9-CM
codes, which are useful for insurance reimbursement but
may not be exact substitutes for precise operative defini-
tions. There is also lack of data whether ETCO2 monitor-
ing was performed during or after chest compressions.
We validated the selection processes by analyzing 150
medical records of patients with OHCA randomly
Table 2 Frequency of ETCO2 use
Frequency of ETCO2 use
Year ETCO2 use Untreated group
NO. % NO. %
2005 7 1.32 522 98.68
2006 2 0.35 571 99.65
2007 5 0.86 574 99.14
2008 7 1.04 666 98.96
2009 0 0 643 100
2010 7 1.07 646 98.93
2011 14 2.03 675 97.97
2012 41 5.84 661 94.16
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Table 3 Baseline characteristics in the propensity-matched cohort
Variables ETCO2 group Untreated group P value
(n = 53) (n = 1060)
Male, no. (%) 27 50.9 644 60.8 0.154
Mean age in years (SD) 68.9 15.9 69.6 16.7 0.776
Attempted defibrillation, no. (%) 11 20.8 183 17.3 0.513
Mean CPR time (10 min) (SD) 2.7 1.4 2.5 1.6 0.394
Socioeconomic status, no. (%) 0.864
Low 38 71.7 727 68.6
Moderate 14 26.4 316 29.8
High 1 1.9 17 1.6
Urbanization level, no. (%) 0.929
Urban 13 24.5 276 26.0
Suburban 23 43.4 469 44.3
Rural 17 32.1 315 29.7
Diabetes, no. (%) 11 20.8 272 25.7 0.424
Hypertension, no. (%) 26 49.1 521 49.2 0.989
Coronary artery disease, no. (%) 10 18.9 200 18.9 1.000
Hyperlipidemia, no. (%) 10 18.9 211 19.9 0.853
Malignancies, no. (%) 3 5.7 44 4.2 0.594
Heart failure, no. (%) 1 1.9 19 1.8 0.959
Atrial fibrillation, no. (%) 1 1.9 16 1.5 0.827
Charlson Comorbidity Index score, no. (%) 0.935
0 19 35.9 355 33.5
1 15 28.3 305 28.8
≥ 2 19 35.9 400 37.7
Intracerebral hemorrhage, no. (%) 1 1.9 26 2.5 0.794
Ischemic stoke, no. (%) 8 15.1 198 18.7 0.512
Chronic renal insufficiency, no. (%) 2 3.8 36 3.4 0.883
Liver cirrhosis, no. (%) 4 7.6 128 12.1 0.320
Health care institutes, no. (%) 0.959
Medical centers 15 28.3 288 27.2
Regional hospitals 32 60.4 639 60.3
Local hospitals 6 11.3 133 12.6
Clinics 0.0209 0.0125 0.0207 0.0125 0.917
Table 4 Comparison of ORs and risk differences among the original group and matched cohorts
ETCO2 group (n) Untreated group (n) ORs (95 % CI) Risk differences (95 % CI)
Original group ROSC(+) 25 633 2.95 (1.83–4.74) 0.17 (0.07–0.27)
ROSC(−) 58 4325
1:4 matched cohort ROSC(+) 25 56 2.12 (1.23–3.68) 0.13 (0.02–0.23)
ROSC(−) 58 276
1:20 matched cohort ROSC(+) 15 150 2.39 (1.29–4.46) 0.14 (0.02–0.26)
ROSC(−) 38 910
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selected from the electronic database from 2010 to 2012
at Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical
Foundation. All 118 patients who were charged with chest
compression had documented CPR records. Among 69
patients with ETCO2 charge records, the confirmation of
use was found by documented CO2 levels during resusci-
tations. All 42 patients with records of hospitalization
were alive before admissions. These selection processes
yielded positive predictive values of 100 %.
Second, the percentage of ETCO2 monitoring in our
study cohort was only 1.6 %, which may be an underesti-
mate of the true number of patients who actually were
monitored. In clinical practice in Taiwan, procedures are
charged either by healthcare or administrative staff. In a
busy situation such as resuscitation, staff may forget to
charge for the ETCO2 monitoring in some patients. Al-
though the extent of crossover to the treatment category
cannot be assessed in this study, according to the
intention-to-treat analytical principle, the result in this
study would show only a bias toward a null result, and
the estimation of OR would be more conservative than
the actual number reported.
Third, the overall percentage of sustained ROSC
(13 %) is low compared with results reported in other
publications [20, 21]. Results similar to ours were found
in a study published by Huang et al. [22], and fewer
shockable rhythms in that study may account for the
similarity. Because of the limited number of cases, we
failed to find benefits of ETCO2 monitoring on patients’
survival to hospital discharge. Further study should be
conducted to evaluate if chest compression monitoring
by ETCO2 can improve survival to hospital discharge
and, perhaps, if it can be associated with better cerebral
performance.
Fourth, for an observational study, confounding by in-
dication may be a concern even after one applies pro-
pensity score matching to establish the comparability
between groups that use ETCO2 monitoring or do not.
For example, in patients with a lower likelihood of sur-
vival, physicians may be less likely to use ETCO2 moni-
toring during resuscitation. However, because the
outcome of survival is not perfectly predictable before-
hand, such an argument is not plausible. Moreover, be-
cause the baseline characteristics were similar between
the ETCO2 group and the untreated group even before
matching, we believe that resuscitation teams would
use ETCO2 monitoring guidelines instead of clinical
judgments.
Fig. 2 Sensitivity analyses for an unmeasured confounding factor
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Fifth, with the use of propensity score analyses to ad-
just for possible confounding, we also lost the ability to
evaluate other possible covariates of survival. Finally, al-
though we extensively adjusted for many possible covari-
ates, unmeasured confounding and the possibility of
overmatching may still exist. In our database, we were
unable to obtain prehospital information such as by-
stander CPR, prehospital intubation, and duration of
collapse.
Conclusion
Patients monitored with ETCO2 may have a higher pos-
sibility of sustained ROSC. However, the overall use of
ETCO2 is still low despite strong recommendations in
guidelines.
Additional file
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